Asia-Pacific LIMS market is expected to reach USD 287.59 million by 2025 from USD 148.36 million in 2017, at the highest CAGR of 8.9% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
The major factors contributing to the growth of the market includes factors such as growing use of LIMS to comply with stringent regulatory requirements, rising need for adoption of LIMS in various industries, technological advancements in LIMS services are boosting the growth of the Asia-Pacific LIMS market.

The key market players for Asia-Pacific LIMS market are listed below;

Thermo Fisher Scientific
Siemens AG
Abbott
McKesson Corporation
Roper Technologies, Inc.
IBM Corporation
Illumina, Inc.
Shimadzu Corporation
LabWare
LABWORKS
The market is further segmented into;
Component
Product Type
Delivery
Industry Type

The Asia-Pacific LIMS market is segmented on the basis of component into services and software. In 2018, service is expected to dominate the LIMS market with 68.1% market share and is expected to reach 200.61 million by 2025, growing at the highest CAGR of 9.3% in the forecast period 2018 to 2025.
The Asia-Pacific LIMS market is segmented on the basis of product type into broad-based LIMS and industry-specific LIMS. In 2018, industry-specific is expected to dominate the LIMS market with 63.4% market share and is expected to reach 175.27 million by 2025, growing at a CAGR of 8.3% in the forecast period 2018 to 2025.
The Asia-Pacific LIMS market is segmented on the basis of delivery into on-premise LIMS, cloud-based LIMS and remotely hosted LIMS. In 2018, on-premise LIMS is expected to dominate the LIMS market with 56.8% market share and is expected to reach 155.34 million by 2025, growing at a CAGR of 8.1% in the forecast period 2018 to 2025.
The Asia-Pacific LIMS market is segmented on the basis of industry type into life sciences industry, food & beverage and agriculture industries, petrochemical refineries and the oil & gas industry, chemical industry and other industry. In 2018, life sciences industry is expected to dominate the LIMS market with 51.1% market share and is expected to reach 148.94 million by 2025, growing at a CAGR of 9.1% in the forecast period 2018 to 2025. The life sciences industry is further segmented into pharmaceutical and biotechnology companies, contract service organizations, academic research institutes and molecular diagnostics (MDX) & clinical research laboratories.
The Asia-Pacific LIMS market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.
Based on geography, the Asia-Pacific LIMS market is segmented into geographical regions, such as,
China,
Japan,
India,
South Korea,
Australia,
Thailand,
Malaysia,
Singapore,
Indonesia,
Philippines
Rest of APAC
Covered in this report
The report covers the present scenario and the growth prospects of the Asia-Pacific LIMS for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.